151
Participants
Start Date
March 1, 2022
Primary Completion Date
March 3, 2026
Study Completion Date
March 2, 2027
Daratumumab
Daratumumab will be administered subcutaneously.
Cyclophosphamide
Cyclophosphamide will be administered either orally or IV.
Bortezomib
Bortezomib will be administered by SC injection or IV.
Dexamethasone
Dexamethasone will be administered orally or IV.
Memorial Sloan Kettering, New York
Alexandra General Hospital of Athens, Athens
Charite Campus Benjamin Franklin, Berlin
West Penn Hospital, Pittsburgh
VCU Medical Center, Richmond
Fondazione IRCCS Policlinico San Matteo, Pavia
Wake Forest University - Baptist Medical Center, Winston-Salem
Clinica Univ. de Navarra, Madrid
Levine Cancer Institute, Charlotte
Winship Cancer Institute Emory University, Atlanta
Clinica Univ. de Navarra, Pamplona
CHU Rangueil, Toulouse
Moffitt Cancer Center, Tampa
Hosp Clinico Univ de Salamanca, Salamanca
Ohio Health Research Institute, Columbus
University Hospital of Cleveland, Cleveland
Universitatsklinikum Essen, Essen
Barbara Ann Karmanos Cancer Institute, Detroit
Universitaetsklinikum Heidelberg Medizinische Klinik V, Heidelberg
Centre hospitalier Lyon-Sud, Pierre-Bénite
UT Southwestern Medical Center, Dallas
Università Degli Studi Di Napoli Federico Ii, Napoli
CHU De Poitiers, Poitiers
CHU de Limoges, Limoges
University of Washington, Seattle
City of Hope, Duarte
Peking University First Hospital, Beijing
Peking University People s Hospital, Beijing
Ruijin Hospital Shanghai Jiao Tong University, Shanghai
First affiliated Hospital of Zhejiang University, Hangzhou
West China Hospital Si Chuan University, Chengdu
Smilow Cancer Hospital/Yale Cancer Center, New Haven
Tufts Medical Center, Boston
Boston University Medical Center, Boston
Tom Baker Cancer Center, Calgary
Cross Cancer Institute, Edmonton
University Health Network UHN Princess Margaret Cancer Centre, Toronto
DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA - UNIVERSITà ''LA SAPIENZA'', Roma
University Medical Center Groningen, Groningen
Hospital Maastricht University Medical Center, Maastricht
UMC Utrecht, Utrecht
Hosp. Univ. Germans Trias I Pujol, Badalona
Hosp Univ Vall D Hebron, Barcelona
Hosp Clinic de Barcelona, Barcelona
Leicester Royal Infirmary - Haematology, Leicester
University College Hospital, London
Janssen Research & Development, LLC
INDUSTRY